mRNA Vaccines - Search News

melanoma, mRNA vaccine

Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial

Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a trial.

Nature · 3d

Moderna mRNA vaccine almost halves the risk of skin cancer returning

MedPage Today on MSN · 2d

mRNA melanoma vaccine cuts risk of recurrence or death, leaked trial data show

· 2d

A personalized cancer vaccine could be available as soon as 2027. Here’s what we know

Moderna and Merck are preparing to seek regulatory approval after their experimental melanoma vaccine delivered promising results in a late-stage clinical trial.

· 2d

A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study

New Scientist · 2d

Personalised cancer vaccine expected to be approved next year

· 2d

These Melanoma Patients Got a Vaccine Made for Their Own Tumors. 2 Years Later, 82% Are Still Cancer-Free

People given intismeran in combination with a standard immunotherapy drug were substantially less likely to have their cancer return two years later and are likely living longer than those only given ...

Yahoo · 2d

Custom-built skin cancer vaccine almost halves death risk

· 2d

Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip

STAT

After a cancer vaccine’s first success, the race is on to expand the impact

After 100 years, there's finally an effective cancer vaccine. Now comes the push to get them to work in more tumor types.

YourLifeChoices

Cancer vaccine breakthrough offers new hope after melanoma surgery

Each vaccine is built for one person alone. Researchers read the tumour’s unique neoantigen fingerprint, then create a ‘wanted poster’ of the cancer. It is delivered as mRNA

9don MSN

Head-to-head comparison of three mRNA vaccines reveals differences in their stability in human blood

A study by Australian researchers compared three mRNA-LNP vaccine platforms in human blood samples, generating findings that could advance cancer treatment and vaccine design.

12don MSN

Sequence changes help modified mRNA avoid protein-making errors to improve vaccine design

When the coronavirus SARS-CoV-2 turned our world upside down, mRNA vaccines against COVID-19 brought a breakthrough. Their success established modified mRNA as a powerful foundation for vaccines and opened the way for new mRNA-based technologies,

Lab study shows needle-free mRNA vaccine protects against COVID and flu

A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.

Asianet Newsable on MSN

MRNA stock’s vaccine rally cracks as worst week in 3 months looms — analyst calls it a ‘do-not-trade’ over wild swings

Mizuho analyst Jared Holz said the vaccine data weren’t bad, but Wall Street’s expectations were too high.